Evidence-based Laboratory Test Order Sets in Primary Care

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Completed
CT.gov ID
NCT02950142
Collaborator
KU Leuven (Other), University Ghent (Other), Norwegian Institute of Public Health (Other), Sciensano (Other)
288
1
2
20
14.4

Study Details

Study Description

Brief Summary

Cluster randomised controlled trial to evaluate what the effect is of evidence-based order sets aimed at five indications on the appropriateness of laboratory test ordering in primary care.

Detailed Description

Cluster randomised controlled trial in Belgian primary care practices. Participants will be primary care physicians working in primary care practices affiliated to one of three collaborating laboratories in the Leuven, Ghent or Antwerp regions.

Primary care practices will be allocated and randomized to either the intervention or control group. Physicians in PCPs randomized to the intervention will be offered order sets based on indication when using the CPOE for ordering laboratory tests. The effect of order sets will be analyzed for 17 common indications for ordering laboratory tests in Belgian primary care: diabetes mellitus, hypertension, cardiovascular disease, general check-up, unexplained fatigue, anemia, liver pathology, medication monitoring, gout, chronic kidney disease, lung embolism, acute coronary syndrome, diarrhea, thyroid disease, sexually transmitted disease, rheumatoid arthritis and obesity.

Study Design

Study Type:
Interventional
Actual Enrollment :
288 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Diagnostic
Official Title:
The Effect of Evidence-based Order Sets Within a CPOE System on the Quantity and Quality of Laboratory Test Ordering in Family Practice: a Cluster Randomised Trial
Actual Study Start Date :
Dec 1, 2017
Actual Primary Completion Date :
Jun 1, 2018
Actual Study Completion Date :
Aug 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: CPOE with order sets

Physicians who use CPOE including order sets for large range of indications.

Other: CPOE with order sets for lab testing
CPOE including series of recommended tests ordered per indication
Other Names:
  • CPOE with order sets for laboratory testing
  • Active Comparator: CPOE without order sets

    Physicians who use CPOE without order sets.

    Other: CPOE without order sets for lab testing
    CPOE only
    Other Names:
  • CPOE without order sets for laboratory testing
  • Outcome Measures

    Primary Outcome Measures

    1. Appropriateness [3 months]

      number of appropriate tests for 17 study indications

    Secondary Outcome Measures

    1. Missed or delayed diagnoses [1 year]

      Incidence of missed or delayed diagnoses after laboratory test

    2. Laboratory test volume [1 year]

      Total volume of ordered laboratory tests

    Other Outcome Measures

    1. Downstream or cascade clinical activities [1 year]

      All downstream or cascade clinical activities as a result of abnormal test result

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Primary care practices will be considered eligible if all the physicians active in the practice agree to be involved in the study

    • All family physicians will be considered eligible if they:

    • Collaborate with either MCH, Anacura or AML for their laboratory test orders

    • Agree to use the online CPOE for their laboratory test orders

    • Use a computerized EHR for patient care

    • Agree to the terms in the informed consent

    Exclusion Criteria:
    • Primary care practices where one or more physicians refuse to be enrolled will be excluded

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Academic Centre for General Practice Leuven Belgium B-3000

    Sponsors and Collaborators

    • Universitaire Ziekenhuizen Leuven
    • KU Leuven
    • University Ghent
    • Norwegian Institute of Public Health
    • Sciensano

    Investigators

    None specified.

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    Universitaire Ziekenhuizen Leuven
    ClinicalTrials.gov Identifier:
    NCT02950142
    Other Study ID Numbers:
    • S59472
    • CB1611
    First Posted:
    Oct 31, 2016
    Last Update Posted:
    Jan 23, 2020
    Last Verified:
    Jan 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Universitaire Ziekenhuizen Leuven
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 23, 2020